Advanced Medical Solutions Group plc
AMS.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £424 | £449 | £561 | £729 |
| - Cash | £17 | £60 | £82 | £73 |
| + Debt | £87 | £9 | £10 | £10 |
| Enterprise Value | £493 | £398 | £488 | £666 |
| Revenue | £178 | £126 | £124 | £109 |
| % Growth | 40.7% | 1.5% | 14.5% | – |
| Gross Profit | £83 | £70 | £69 | £56 |
| % Margin | 46.6% | 55.6% | 55.2% | 51.7% |
| EBITDA | £30 | £31 | £35 | £32 |
| % Margin | 16.7% | 24.9% | 28.1% | 29.1% |
| Net Income | £7 | £16 | £20 | £17 |
| % Margin | 4% | 12.6% | 16.4% | 16.1% |
| EPS Diluted | 0.033 | 0.073 | 0.093 | 0.08 |
| % Growth | -55.2% | -22% | 16.1% | – |
| Operating Cash Flow | £17 | £12 | £27 | £30 |
| Capital Expenditures | -£4 | -£10 | -£10 | -£6 |
| Free Cash Flow | £13 | £2 | £17 | £24 |